Try a new search

Format these results:

Searched for:

person:adotap01

in-biosketch:true

Total Results:

23


Barber Knowledge and Recommendations Regarding Pseudofolliculitis Barbae and Acne Keloidalis Nuchae in an Urban Setting [Letter]

Adotama, Prince; Tinker, Daniel; Mitchell, Krystal; Glass, Donald A; Allen, Pamela
PMCID:5817432
PMID: 29049485
ISSN: 2168-6084
CID: 4502662

Association of keloids with systemic medical conditions: a retrospective analysis [Letter]

Adotama, Prince; Rutherford, Audrey; Glass, Donald A
PMID: 26517298
ISSN: 1365-4632
CID: 4502642

Patient satisfaction with different treatment modalities for vitiligo [Letter]

Adotama, Prince; Zapata, Lucio; Currimbhoy, Sharif; Hynan, Linda S; Pandya, Amit G
PMID: 25773415
ISSN: 1097-6787
CID: 4502632

Assessing the use of methotrexate as an alternate therapy for pemphigus vulgaris and pemphigus foliaceus

Kolla, Avani; Shah, Payal; Cymerman, Rachel; Fruchter, Renee; Adotama, Prince; Soter, Nicholas A
Methotrexate is historically recognized as an effective treatment of pemphigus but its utility as a single or alternate steroid-sparing agent was not recognized in recent consensus recommendations in pemphigus management. We aimed to evaluate the efficacy and safety of a treatment course for pemphigus that involves methotrexate as a single or steroid-sparing agent. In a retrospective cohort study, we examined patients with pemphigus vulgaris or pemphigus foliaceus who were on ≥3 months of methotrexate therapy. Efficacy and safety were evaluated by established pemphigus disease endpoints. Of the 34 patients who met inclusion criteria, 25 (73.5%) were on glucocorticoids at time of methotrexate initiation (median follow-up: 5.4 years; median time on methotrexate: 3.7 years). An appreciable proportion achieved disease control (91.2%), with some achieving clinical remission off all systemic therapies (23.5%). For patients on glucocorticoids, median time to control was 42 days, median time to minimal steroid dose tapering (5 mg prednisone) was 161 days, and median time to complete steroid tapering was 308 days. For patients on methotrexate as a single agent, median time to control was 119 days. Among all patients, relapse commonly occurred (88.2%). At last follow-up, 26.5% were managed on topical therapies alone and 11.8% required systemic steroid therapy. Methotrexate was largely tolerated with a low incidence of adverse events leading to treatment discontinuation (2.9%). Methotrexate has the potential to be an effective and well-tolerated option for patients and may be considered for use as an alternate single or steroid-sparing agent for pemphigus.
PMID: 35734997
ISSN: 1529-8019
CID: 5282032

Response to Ranpariya et al.'s "Direct-to-consumer teledermatology platforms may have inherent conflicts of interest." [Letter]

Karim, Maria; Klein, Elizabeth; Gutierrez, Daniel; Adotama, Prince; Lo Sicco, Kristen
PMID: 34998962
ISSN: 1097-6787
CID: 5118172

Enlarging alopecic patch in an African American woman with central centrifugal cicatricial alopecia: A case of concomitant tinea incognito [Case Report]

Klein, Elizabeth J; Karim, Maria; Kushner, Carolyn J; Marji, Jackleen S; Adotama, Prince; Lo Sicco, Kristen; Shapiro, Jerry
PMCID:9014319
PMID: 35445146
ISSN: 2352-5126
CID: 5218422

Dermatologists' knowledge of dermoscopic features in hair and nail disorders [Letter]

Kolla, A; Starace, M; Svigos, K; Yin, L; Rich, P; Krueger, L; Adotama, P; Shapiro, J; Piraccini, B; Lo Sicco, K
PMID: 35148453
ISSN: 1468-3083
CID: 5156942

Revisiting Solitary Pedunculated Lipofibromas

Adotama, Prince; Hutson, Seneca D; Rieder, Evan A; Stein, Jennifer A; Kim, Randie H
OBJECTIVES/OBJECTIVE:Pedunculated lipofibromas are soft, compressible, skin-colored nodules that typically present as an acquired solitary lesion, predominantly located on the buttocks and thighs. We aimed to differentiate between pedunculated lipofibromas and nevus lipomatosus superficialis. Although benign, this may be important as treatment options vary. METHODS:We describe 3 cases of solitary pedunculated lipofibromas occurring in older, obese adults that required clinicopathologic correlation for the correct diagnosis. RESULTS:The histopathologic features of pedunculated lipofibromas include a broad-based lesion with aggregates of mature adipocytes extending upwards into the dermis without an associated inflammatory infiltrate. The primary histopathologic differential diagnoses include fibroepithelial polyps with adipocytes and nevus lipomatosus superficialis, which is more frequently found in children or young adults and is typically characterized clinically by multiple lesions with a cerebriform to verrucoid surface. CONCLUSIONS:While the precise relationship between pedunculated lipofibromas and nevus lipomatosus is still unknown, we propose using pedunculated lipofibroma as a more specific clinical term to refer to solitary pedunculated or broad-based fatty lesions with a smooth surface that occur in older patients and in a wide anatomic distribution.
PMID: 34124747
ISSN: 1943-7722
CID: 4950212

Comparing the clinical differences in white and black women with frontal fibrosing alopecia [Letter]

Adotama, P; Callender, V; Kolla, A; Young, C; Jones, P; Svigos, K; Yin, L; Ugonabo, N; Gutierrez, D; Peterson, E; Lo Sicco, K; Shapiro, J
PMID: 34184243
ISSN: 1365-2133
CID: 5010592

Evaluating the Contributions of Dermatologists in the Management of Systemic Sclerosis: A Retrospective Analysis [Letter]

Rangel, Lauren K; Adotama, Prince; Shah, Payal; Lo Sicco, Kristen; Femia, Alisa
Systemic Sclerosis (SSc) is an autoimmune condition characterized by cutaneous sclerosis and the potential for internal organ involvement.1 Given the multisystem nature of SSc, multiple disciplines are often involved in its management. However, while the skin is affected in more than 90% of patients,2 dermatologists are variably involved in the management of SSc, potentially first evaluating patients only late in the disease course, or at times not at all.
PMID: 33866612
ISSN: 1468-3083
CID: 4878032